• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

达托霉素对包括对利奈唑胺耐药的肠球菌和金黄色葡萄球菌在内的多重耐药革兰氏阳性菌的活性。

Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.

作者信息

Johnson A P, Mushtaq S, Warner M, Livermore D M

机构信息

Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency, Specialist and Reference Microbiology Division, Colindale, London NW9 5HT, UK.

出版信息

Int J Antimicrob Agents. 2004 Oct;24(4):315-9. doi: 10.1016/j.ijantimicag.2004.04.006.

DOI:10.1016/j.ijantimicag.2004.04.006
PMID:15380254
Abstract

The activity of daptomycin was assessed against 545 isolates of Gram-positive bacteria including enterococci, coagulase-positive and -negative staphylococci, beta-haemolytic streptococci, viridans streptococci and coryneforms. The panel of isolates was biased towards those with resistance to first-line antimicrobial agents and included linezolid-resistant enterococci and Staphylococcus aureus. MICs of daptomycin were < or =1mg/l for all the staphylococci, streptococci, and coryneforms, except for two isolates of Corynebacterium aquaticum, for which MICs were 8 mg/l. Daptomycin MICs were < or =2 and < or =4 mg/l for Enterococcus faecalis and Enterococcus faecium, respectively.

摘要

对545株革兰氏阳性菌进行了达托霉素活性评估,这些细菌包括肠球菌、凝固酶阳性和阴性葡萄球菌、β溶血性链球菌、草绿色链球菌和棒状杆菌。分离菌株偏向于那些对一线抗菌药物耐药的菌株,包括耐利奈唑胺的肠球菌和金黄色葡萄球菌。除两株水生棒状杆菌的最低抑菌浓度(MIC)为8mg/l外,所有葡萄球菌、链球菌和棒状杆菌的达托霉素MIC均≤1mg/l。粪肠球菌和屎肠球菌的达托霉素MIC分别≤2mg/l和≤4mg/l。

相似文献

1
Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.达托霉素对包括对利奈唑胺耐药的肠球菌和金黄色葡萄球菌在内的多重耐药革兰氏阳性菌的活性。
Int J Antimicrob Agents. 2004 Oct;24(4):315-9. doi: 10.1016/j.ijantimicag.2004.04.006.
2
Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.达托霉素、利奈唑胺和奎奴普丁/达福普汀对某大型癌症中心革兰氏阳性菌分离株的体外活性比较
Diagn Microbiol Infect Dis. 2005 Jul;52(3):255-9. doi: 10.1016/j.diagmicrobio.2005.02.015.
3
In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.达托霉素对耐利奈唑胺和奎奴普丁/达福普汀的临床分离株的体外活性
Int J Antimicrob Agents. 2006 Nov;28(5):385-8. doi: 10.1016/j.ijantimicag.2006.07.017.
4
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).亚太地区革兰氏阳性菌分离株的抗菌药敏性以及达托霉素、万古霉素和替考拉宁杀菌活性的体外评估:哨兵计划报告(2003 - 2004年)
Int J Antimicrob Agents. 2007 Aug;30(2):143-9. doi: 10.1016/j.ijantimicag.2007.03.015. Epub 2007 May 24.
5
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.台湾地区达托霉素、糖肽类、利奈唑胺和替加环素对革兰氏阳性菌血液分离株的杀菌活性比较
Clin Microbiol Infect. 2008 Feb;14(2):124-9. doi: 10.1111/j.1469-0691.2007.01888.x. Epub 2007 Dec 10.
6
Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.2005年恶唑烷酮类药敏模式:来自Zyvox年度效力与谱研究的国际报告
Int J Antimicrob Agents. 2007 Mar;29(3):295-301. doi: 10.1016/j.ijantimicag.2006.09.025. Epub 2007 Jan 18.
7
Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.左氟沙星年度效价和光谱评估计划:利奈唑胺监测计划 2008 年结果。
Diagn Microbiol Infect Dis. 2009 Dec;65(4):404-13. doi: 10.1016/j.diagmicrobio.2009.10.001.
8
Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).从美国医疗中心分离出的革兰氏阳性菌的抗菌药敏性:达托霉素监测项目(2007 - 2008年)的结果
Diagn Microbiol Infect Dis. 2009 Oct;65(2):158-62. doi: 10.1016/j.diagmicrobio.2009.06.016.
9
Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).从欧洲医疗中心分离出的革兰氏阳性菌的抗菌药敏性:达托霉素监测计划(2002 - 2004年)的结果
Clin Microbiol Infect. 2006 Sep;12(9):844-52. doi: 10.1111/j.1469-0691.2006.01550.x.
10
[Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].达托霉素对革兰氏阳性微生物的体外比较活性:西班牙哨兵监测项目(2002 - 2006年)
Enferm Infecc Microbiol Clin. 2008 Oct;26(8):489-94.

引用本文的文献

1
Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital.三级医院耐甲氧西林凝固酶阴性葡萄球菌菌血症的临床特征
Intern Med. 2017;56(7):781-785. doi: 10.2169/internalmedicine.56.7715. Epub 2017 Apr 1.
2
Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital.希腊一家三级医院中耐糖肽肠球菌对利奈唑胺、奎奴普丁/达福普汀、替加环素和达托霉素的敏感性
Infect Chemother. 2014 Dec;46(4):253-6. doi: 10.3947/ic.2014.46.4.253. Epub 2014 Dec 29.
3
Genetic modifications to temperate Enterococcus faecalis phage Ef11 that abolish the establishment of lysogeny and sensitivity to repressor, and increase host range and productivity of lytic infection.
温和性粪肠球菌噬菌体 Ef11 的遗传修饰,消除了溶原性的建立和对阻遏物的敏感性,并增加了裂解感染的宿主范围和生产力。
Microbiology (Reading). 2013 Jun;159(Pt 6):1023-1035. doi: 10.1099/mic.0.067116-0. Epub 2013 Apr 11.
4
Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA).耐甲氧西林金黄色葡萄球菌(MRSA)对达托霉素的敏感性
Indian J Med Res. 2012 Oct;136(4):676-7.
5
Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.评估标准剂量和高剂量达托霉素与利奈唑胺对模拟心内膜赘生物的体外药代动力学/药效学模型中万古霉素耐药肠球菌分离株的作用。
Antimicrob Agents Chemother. 2012 Jun;56(6):3174-80. doi: 10.1128/AAC.06439-11. Epub 2012 Apr 2.
6
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).针对2005年在欧洲医疗中心分离出的耐甲氧西林葡萄球菌和耐万古霉素肠球菌测试达托霉素的抗菌活性。
BMC Infect Dis. 2007 Apr 18;7:29. doi: 10.1186/1471-2334-7-29.
7
Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates.用于区分对达托霉素敏感与不敏感的金黄色葡萄球菌分离株的Etest法和纸片扩散法的多中心评估
J Clin Microbiol. 2006 Sep;44(9):3098-104. doi: 10.1128/JCM.00665-06.
8
In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin.达托霉素联合利福平对耐利奈唑胺和万古霉素的屎肠球菌的体外协同作用
Antimicrob Agents Chemother. 2005 Dec;49(12):5166-8. doi: 10.1128/AAC.49.12.5166-5168.2005.
9
Agents for the Treatment of Multidrug-resistant Gram-positive Endocarditis.耐多药革兰氏阳性菌心内膜炎的治疗药物
Curr Infect Dis Rep. 2005 Jul;7(4):245-250. doi: 10.1007/s11908-005-0055-4.